New blood purification therapy for sepsis under Real-World scrutiny
Disease control
Recruiting now
This registry study is following 200 adults with sepsis or septic shock who receive ARTICE® therapy in the ICU. Researchers are tracking organ function, survival, and complications to see how well the treatment works in everyday practice. The goal is to identify which patients be…
Sponsor: Artcline GmbH • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC